Bexsero
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
All newborn babies in the UK are now routinely offered the jab against Meningococcal group B (MenB), but there is still work to…
Background: Meningococcal vaccines in current use contain the capsular polysaccharides of serogroups A, C, Y, and W-135…
Bexsero, a 4 component protein-based meningococcal B vaccine (4CMen B)
manufactured by Novartis was authorised for use by the…